Evidence map›Paper›PMID 26463421›Full record

ArticleScientific reports2015

Controllable degradation kinetics of POSS nanoparticle-integrated poly(ε-caprolactone urea)urethane elastomers for tissue engineering applications.

Lara Yildirimer, Asma Buanz, Simon Gaisford, Edward L Malins, C Remzi Becer, Naiem Moiemen, Gary M Reynolds, Alexander M Seifalian

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lara YildirimerCentre for Nanotechnology &Regenerative Medicine, UCL Division of Surgery &Interventional Science, University College London.
Asma BuanzUCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.
Simon GaisfordUCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.
Edward L MalinsDepartment of Chemistry, University of Warwick, CV4 7AL, Coventry, UK.
C Remzi BecerSchool of Engineering and Materials Science, Queen Mary University of London, E1 4NS, London, UK.
Naiem MoiemenDepartment of Burns and Plastic Surgery, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, United Kingdom.
Gary M ReynoldsCentre for Liver Research &NIHR BRU, Queen Elizabeth Hospital &University of Birmingham.
Alexander M SeifalianCentre for Nanotechnology &Regenerative Medicine, UCL Division of Surgery &Interventional Science, University College London.

Funding

Medical Research Council
6 · The paper itself

Abstract

Biodegradable elastomers are a popular choice for tissue engineering scaffolds, particularly in mechanically challenging settings (e.g. the skin). As the optimal rate of scaffold degradation depends on the tissue type to be regenerated, next-generation scaffolds must demonstrate tuneable degradation patterns. Previous investigations mainly focussed on the integration of more or less hydrolysable components to modulate degradation rates. In this study, however, the objective was to develop and synthesize a family of novel biodegradable polyurethanes (PUs) based on a poly(ε-caprolactone urea)urethane backbone integrating polyhedral oligomeric silsesquioxane (POSS-PCLU) with varying amounts of hard segments (24%, 28% and 33% (w/v)) in order to investigate the influence of hard segment chemistry on the degradation rate and profile. PUs lacking POSS nanoparticles served to prove the important function of POSS in maintaining the mechanical structures of the PU scaffolds before, during and after degradation. Mechanical testing of degraded samples revealed hard segment-dependent modulation of the materials' viscoelastic properties, which was attributable to (i) degradation-induced changes in the PU crystallinity and (ii) either the presence or absence of POSS. In conclusion, this study presents a facile method of controlling degradation profiles of PU scaffolds used in tissue engineering applications.

Indexed as

Absorbable ImplantsTissue ScaffoldsElastic ModulusElastomersEquipment Failure AnalysisKineticsMaterials TestingNanoconjugatesOrganosilicon CompoundsParticle SizePolyestersProsthesis DesignTensile StrengthTissue EngineeringUrethaneViscosityElastomersNanoconjugatesOrganosilicon CompoundspolycaprolactonePolyesterspolyhedraloligosilsesquioxaneUrethane

Identifiers

PMID26463421
PMCPMC4604490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.